Current and Future Management of Brain MetastasisEditor(s): Kim D.G. (Seoul)
Lunsford L.D. (Pittsburgh, Pa.)
Understanding Brain Metastasis
Epidemiology of Central Nervous System MetastasesAlexandru D.a · Bota D.A.a,b · Linskey M.E.a
Departments of aNeurological Surgery and bNeurology, University of California, Irvine, Calif., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Brain metastases are overwhelmingly the most common type of brain tumor, out numbering primary brain tumors in incidence by more than four-to-one. They are associated with poor prognosis both from a length-of-life as well as a quality-of-life standpoint. Once the brain metastasis is detected, without treatment, most patients die within months, either from widespread systemic disease, or due to the brain metastasis itself. The complications of brain metastases are also devastating. Patients can suffer from seizures, weakness or paralysis, language and communication deficits, as well as cognitive decline. These complications negatively impact on quality of life through effects on functional independence, impairment of capacity to participate in activities and relationships, as well as distortion of individual personality and identity. At the same time, there are great financial burdens associated with both the care and treatment of patients with brain metastases. Early detection of brain metastases in cancer patients is critical for limiting these complications, minimizing these burdens and improving the outlook regarding both survival and quality of life. Understanding the epidemiology of brain metastases can lead to the development of new strategies for the early identification and successful treatment of these patients.
© 2012 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.